financetom
Business
financetom
/
Business
/
Coca-Cola's Q2 Comparable Earnings, Revenue Increase
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coca-Cola's Q2 Comparable Earnings, Revenue Increase
Jul 23, 2024 4:38 AM

07:24 AM EDT, 07/23/2024 (MT Newswires) -- Coca-Cola (KO) reported Q2 comparable earnings Tuesday of $0.84 per diluted share, up from $0.78 a year earlier.

Analysts polled by Capital IQ expected adjusted EPS of $0.81.

Revenue for the quarter ended June 28 was $12.36 billion, compared with $11.97 billion a year earlier.

Analysts surveyed by Capital IQ expected $11.75 billion.

Coca-Cola shares were nearly 1% higher in premarket trading.

Price: 65.48, Change: +0.71, Percent Change: +1.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Brown-Forman Expected to Issue 'More Cautious' Fiscal 2025 Outlook as Pressures Persist, RBC Says
Brown-Forman Expected to Issue 'More Cautious' Fiscal 2025 Outlook as Pressures Persist, RBC Says
May 30, 2024
02:22 PM EDT, 05/30/2024 (MT Newswires) -- Brown-Forman (BF.B) is expected to issue more cautious fiscal 2025 guidance amid continued pressures. particularly in the US, RBC Capital Markets said in a report Thursday. US macros, slowing away from home, muted performance for key brands and a boost promotional spending by rivals suggest a cautious stance, RBC said. Margins have been...
Update: Market Chatter: Skydance Improves Offer for Paramount
Update: Market Chatter: Skydance Improves Offer for Paramount
May 30, 2024
02:20 PM EDT, 05/30/2024 (MT Newswires) -- (Updates with MT Newswires' attempt for comment in the second paragraph) Paramount Global ( PARAA ) received a sweetened merger offer from Skydance Media that Paramount directors are expected to assess shortly, the Wall Street Journal reported, citing people familiar with the situation. Neither Paramount nor Skydance immediately responded to MT Newswires' request...
Catalyst Pharmaceuticals Gets FDA Approval for Dose Increase in LEMS Drug
Catalyst Pharmaceuticals Gets FDA Approval for Dose Increase in LEMS Drug
May 30, 2024
02:23 PM EDT, 05/30/2024 (MT Newswires) -- Catalyst Pharmaceuticals ( CPRX ) said Thursday that the US Food and Drug Administration approved its supplemental new drug application to increase daily dose of Firdapse, a treatment of Lambert-Eaton myasthenic syndrome, an autoimmune disease. The FDA approved maximum increase in Firdapse daily dose from 80 milligrams to 100 milligrams for treatment of...
Saudi Arabia to sell 0.64% Aramco stake
Saudi Arabia to sell 0.64% Aramco stake
May 30, 2024
(Reuters) - Saudi Arabia is selling a 0.64% stake in oil giant Aramco as the kingdom pushes ahead with Crown Prince Mohammed bin Salman's plan to diversify the economy. Saudi Arabia is offering 1.545 billion Aramco shares and the offering period will commence on June 2. The price range is expected to be between SAR 26.70 and SAR 29.00 per...
Copyright 2023-2026 - www.financetom.com All Rights Reserved